Liverly is one of the first mixed reality therapeutic tools in the world designed for Nonalcoholic Fatty Liver Disease (NAFLD), a chronic condition affecting 32% of the global population with no pharmaceutical treatments available. Using circadian rhythm and autophagy research, Liverly transforms complex medical insights into an immersive, interactive experience, allowing users to see and engage with their liver’s healing process in real-time. By merging scientific innovation with spatial therapeutics, Liverly empowers individuals to take control of their liver health in ways never before possible.